Current concepts on coronary revascularization in diabetic patients
Roffi et al.
Eur Heart J 2011;32:2748-2757.
ABSTRACT
| FULL TEXT
Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression
Faraday et al.
Blood 2011;118:3367-3375.
ABSTRACT
| FULL TEXT
Antiplatelet therapy in percutaneous coronary intervention: is variability of response clinically relevant?
Curzen and Sambu
Heart 2011;97:1433-1440.
FULL TEXT
Overexpression of the Multidrug Resistance Protein-4 Transporter in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Cause of Aspirin Resistance?
Eikelboom and Hankey
J Am Coll Cardiol 2011;58:762-764.
FULL TEXT
Aspirin Resistance: A Clinical Review Focused on the Most Common Cause, Noncompliance
Schwartz
The Neurohospitalist 2011;1:94-103.
ABSTRACT
| FULL TEXT
Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
Capodanno et al.
Circ Cardiovasc Interv 2011;4:180-187.
ABSTRACT
| FULL TEXT
Aspirin: A Historical and Contemporary Therapeutic Overview
Fuster and Sweeny
Circulation 2011;123:768-778.
FULL TEXT
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Ferreiro and Angiolillo
Circulation 2011;123:798-813.
FULL TEXT
Chapter 36 Coagulation and thrombosis
Hvas et al.
The ESC Textbook of Acute and Intensive Cardiac Care 2010;1:med-9780199584314-chapter-med-9780199584314-chapter.
ABSTRACT
| FULL TEXT
Review article: Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease
Ferreiro et al.
Diabetes and Vascular Disease Research 2010;7:274-288.
ABSTRACT
Platelet Function Testing for Aspirin Resistance Is Reasonable to Do: Yes!
Alberts
Stroke 2010;41:2400-2401.
FULL TEXT
Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery
Mahla et al.
Ann. Thorac. Surg. 2010;90:1040-1051.
ABSTRACT
| FULL TEXT
Patients With Previous Definite Stent Thrombosis Have a Reduced Antiplatelet Effect of Aspirin and a Larger Fraction of Immature Platelets
Wurtz et al.
J Am Coll Cardiol Intv 2010;3:828-835.
ABSTRACT
| FULL TEXT
Long-Term Aspirin and Clopidogrel Response Evaluated by Light Transmission Aggregometry, VerifyNow, and Thrombelastography in Patients Undergoing Percutaneous Coronary Intervention
Madsen et al.
Clin. Chem. 2010;56:839-847.
ABSTRACT
| FULL TEXT
The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease
Wurtz et al.
Heart 2010;96:368-371.
ABSTRACT
| FULL TEXT
Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation
Lev et al.
J Am Coll Cardiol 2010;55:114-121.
ABSTRACT
| FULL TEXT
Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization
Frelinger et al.
Circulation 2009;120:2586-2596.
ABSTRACT
| FULL TEXT
Aspirin "resistance" and its impact on cardiovascular morbidity and mortality: it is real, clinically relevant and should be measured
Brister and Buchanan
Heart 2009;95:1223-1224.
FULL TEXT
Aspirin resistance testing not ready for "prime time"
Hjemdahl
Heart 2009;95:1220-1222.
FULL TEXT
Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Chen et al.
Circulation 2009;119:3207-3214.
ABSTRACT
| FULL TEXT
Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
Angiolillo
Diabetes Care 2009;32:531-540.
FULL TEXT
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays: Implications for Aspirin "Resistance"
Santilli et al.
J Am Coll Cardiol 2009;53:667-677.
ABSTRACT
| FULL TEXT
Aspirin Resistance: Transient Laboratory Finding or Important Clinical Entity?
Lev
J Am Coll Cardiol 2009;53:678-680.
FULL TEXT
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
Kuliczkowski et al.
Eur Heart J 2009;30:426-435.
ABSTRACT
| FULL TEXT
Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay: A 12-Month Follow-Up
Marcucci et al.
Circulation 2009;119:237-242.
ABSTRACT
| FULL TEXT
Antiplatelet agents
Varon and Spectre
ASH Education Book 2009;2009:267-272.
ABSTRACT
| FULL TEXT
Should we monitor platelet function during antiplatelet therapy?
Hjemdahl
Heart 2008;94:685-687.
FULL TEXT
The implications of aspirin resistance in renal failure
Thachil
Clin Kidney J 2008;1:192-193.
FULL TEXT
Laboratory-Defined Aspirin Resistance and Recurrent Cardiovascular Events
Fontana and Reny
Arch Intern Med 2008;168:549-550.
FULL TEXT
Is Aspirin Resistance Due to Noncompliance?
Dalen
Arch Intern Med 2008;168:550-550.
FULL TEXT
Is Aspirin Resistance Due to Noncompliance?--Reply
Snoep et al.
Arch Intern Med 2008;168:550-550.
FULL TEXT
Aspirin Resistance: Biological and Clinical Implications
Tseeng and Arora
J CARDIOVASC PHARMACOL THER 2008;13:5-12.
ABSTRACT
Aspirin resistance in cardiovascular disease
Biondi-Zoccai and Lotrionte
BMJ 2008;336:166-167.
FULL TEXT
Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos et al.
BMJ 2008;336:195-198.
ABSTRACT
| FULL TEXT
Testing antiplatelet therapy
Gachet and Aleil
Eur Heart J Suppl 2008;10:A28-A34.
ABSTRACT
| FULL TEXT